1177 Stock Overview
Sino Biopharmaceutical Limited, un holding de inversiones, opera como conglomerado farmacéutico de investigación y desarrollo en la República Popular China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for 1177 from our risk checks.
Sino Biopharmaceutical Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$2.82 |
| 52 Week High | HK$4.73 |
| 52 Week Low | HK$2.57 |
| Beta | 0.52 |
| 1 Month Change | -2.76% |
| 3 Month Change | -15.06% |
| 1 Year Change | -32.05% |
| 3 Year Change | -64.57% |
| 5 Year Change | -45.98% |
| Change since IPO | 15.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1177 | HK Pharmaceuticals | HK Market | |
|---|---|---|---|
| 7D | -6.6% | -1.3% | 0.9% |
| 1Y | -32.0% | -15.2% | -13.2% |
Rentabilidad frente al sector: 1177 obtuvo unos resultados inferiores a los del sector Hong Kong Pharmaceuticals , que el año pasado arrojó un rendimiento del -13.3%.
Rentabilidad vs. Mercado: 1177 obtuvo unos resultados inferiores a los del mercado Hong Kong, que fue del -13.7% el año pasado.
Price Volatility
| 1177 volatility | |
|---|---|
| 1177 Average Weekly Movement | 6.3% |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in HK Market | 14.5% |
| 10% least volatile stocks in HK Market | 3.7% |
Precio estable de las acciones: 1177 no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de 1177 (6%) se ha mantenido estable durante el año pasado.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 25,806 | Eric S. Y. Tse | https://www.sinobiopharm.com |
Sino Biopharmaceutical Limited, sociedad de cartera de inversiones, opera como conglomerado farmacéutico de investigación y desarrollo en la República Popular China. Opera a través de tres segmentos: Medicamentos chinos modernizados y medicamentos químicos, Inversión y Otros. La empresa ofrece medicamentos oncológicos, como Qingkeshu comprimidos, Focus V cápsulas, Annike inyección y Anyue cápsulas; medicamentos para enfermedades hepáticas, como Tianqing ganmei inyección y Runzhong comprimidos dispersables; y medicamentos para el sistema respiratorio, como Tianqing suchang suspensión para inhalación y Tianyun para inyección.
Sino Biopharmaceutical Limited Fundamentals Summary
| 1177 fundamental statistics | |
|---|---|
| Market cap | HK$51.74b |
| Earnings (TTM) | HK$2.00b |
| Revenue (TTM) | HK$28.36b |
26.0x
P/E Ratio1.8x
P/S RatioIs 1177 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1177 income statement (TTM) | |
|---|---|
| Revenue | CN¥26.20b |
| Cost of Revenue | CN¥4.99b |
| Gross Profit | CN¥21.21b |
| Other Expenses | CN¥19.36b |
| Earnings | CN¥1.85b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.10 |
| Gross Margin | 80.95% |
| Net Profit Margin | 7.05% |
| Debt/Equity Ratio | 32.0% |
How did 1177 perform over the long term?
See historical performance and comparisonDividends
1.8%
Current Dividend Yield46%
Payout RatioDoes 1177 pay a reliable dividends?
See 1177 dividend history and benchmarks| Sino Biopharmaceutical dividend dates | |
|---|---|
| Ex Dividend Date | Jun 11 2024 |
| Dividend Pay Date | Jul 05 2024 |
| Days until Ex dividend | 64 days |
| Days until Dividend pay date | 88 days |
Does 1177 pay a reliable dividends?
See 1177 dividend history and benchmarks